More PRNewswire
View Older Stories View Newer Stories-
Travel Leaders Makes It Easy to Plan for Vacation
-
EastGroup Properties Announces the Income Tax Treatment of its 2024 Distributions
-
Aimbridge Hospitality Set to Prioritize Growth and Results in 2025 Following a Year of Transformation
-
Asset Prioritization in Pharma Domain: How In-Licensing Led to the Selection of a High-Value Game-Changing Asset for a Pharma Client
-
Regal Rexnord Corporation Declares Quarterly Dividend of $.35 per share
-
Arizona Entrepreneurs Award President Donald Trump with a Lifetime Achievement Award
-
MIKE TYSON, WINNIE HARLOW, PESO PLUMA, JA RULE, PAUL POGBA AND MORE ATTEND THE 2025 PEGASUS WORLD CUP
-
Sera Prognostics to Host Virtual R&D Day on January 31
-
Ovintiv Names Terri King to Board of Directors
-
IIE CEO Dr. Allan E. Goodman Will Leave Role After Decades of Impact on International Education
-
Evolent To Release Fourth Quarter 2024 Financial Results on Thursday, February 20, 2025
-
HAI Group Named One of the Best Places to Work in Connecticut by the Hartford Business Journal
-
Norfolk Southern names Lori J. Ryerkerk to board of directors
-
MartinPatrick 3 Expands Once Again, Fueled by Rapid Growth in Women's Fashion
-
Liberty Mutual Insurance Issues Statement Regarding 2025 Property Catastrophe Reinsurance Placement
-
Nucor Reports Results for the Fourth Quarter and Full Year 2024
-
LINKBANCORP, Inc. Announces Record Fourth Quarter 2024 and Full Year 2024 Financial Results and Declares Dividend
-
Vistra to Report Full Year and Fourth Quarter 2024 Results on Feb. 27, 2025
-
Cadence Bank Announces Adjournment of its Special Meeting
-
Autozi Internet Technology (Global) Ltd. Announces Fiscal Year 2024 Financial Results and Files Its Annual Report on Form 20-F
-
Health In Tech to Attend the 2025 HCAA Executive Forum with Self-Funding Solutions
-
Lightwave Logic to Attend the 2025 SPIE Photonics West Conference
-
CENTERSPACE ANNOUNCES FOURTH QUARTER 2024 EARNINGS RELEASE DATE
-
Intelligent Living Application Group Inc. Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
ELS REPORTS FOURTH QUARTER RESULTS
-
ASHFORD HOSPITALITY TRUST ANNOUNCES TAX REPORTING INFORMATION FOR 2024 PREFERRED SHARE DISTRIBUTIONS
-
CNX Closes Acquisition of Apex Energy
-
BRAEMAR HOTELS & RESORTS ANNOUNCES TAX REPORTING INFORMATION FOR 2024 COMMON AND PREFERRED SHARE DISTRIBUTIONS
-
Fresh 2025 RE/MAX Advertising Campaign Highlights Agent Trust and Expertise
-
First US Bancshares, Inc. Reports Fourth Quarter and Full-Year 2024 Earnings
-
Advansor Launches Three New CO2 Climate Solutions
-
Jack Henry & Associates Announces Fiscal Second Quarter 2025 Deconversion Revenue Results
-
HOME BANCORP ANNOUNCES 2024 FOURTH QUARTER RESULTS AND INCREASES QUARTERLY DIVIDEND BY 4%
-
Sempra Named to Dow Jones Sustainability Index North America for 14th Consecutive Year
-
Partillion Bioscience Opens Pre-Orders for Nanovial Multicell Assay Kits at SLAS 2025
-
Alexandria Real Estate Equities, Inc. Reports: 4Q24 and 2024 Net (Loss) Income per Share - Diluted of $(0.38) and $1.80, respectively; 4Q24 and 2024 FFO per Share - Diluted, as Adjusted, of $2.39 and
-
Update: Envista Schedules Fourth Quarter 2024 Earnings Call
-
AllianceBernstein Global High Income Fund, Inc. Releases Monthly Portfolio Update
-
AllianceBernstein National Municipal Income Fund, Inc. RELEASES MONTHLY PORTFOLIO UPDATE
-
ALLIANCEBERNSTEIN CLOSED-END FUNDS ANNOUNCE DISTRIBUTION RATES
-
Azitra, Inc. to Present at The Microcap Conference
-
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast
-
SealingTech Achieves Record Production of Cyber-Fly-Away Kits in Q4
-
CPKC reaches tentative collective agreement with Unifor
-
Fresh Tracks Therapeutics Announces Appointment of Custodian and Planned Distribution
-
Safehold Sets Fourth Quarter and Fiscal Year 2024 Earnings Release and Webcast
-
Marlton Partners Comments on Source Capital Proposal to Merge with 180 Degree Capital Corporation
-
Synopsys Announces Earnings Release Date For First Quarter Fiscal Year 2025
-
Neurocrine Biosciences Announces Amendment to Strategic Collaboration with Takeda to Develop and Commercialize Osavampator (formerly NBI-1065845/TAK-653)
-
Alexander & Baldwin Announces Reporting Information for 2024 Dividend Distributions

